|
CTLT | Catalent, Inc. |
|
|
CTLT | Catalent, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | nan |
| Leverage | nan% |
| Market Cap | $ 11.5B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -668.4m |
| Margin | -15.72% |
Catalent, Inc. (Catalent Pharma Solutions) is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products.